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Blood samples from 18 tickborne relapsing fever
(TBRF) patients and Ornithodoros tholozani specimens
were tested with a Borrelia flaB-PCR. Results were positive
for all patients and 2%–40% of ticks. A 7–amino acid gap
characterized all 9 sequenced flagellin gene amplicons. By
phylogenetic analysis, Israel TBRF Borrelia sequences
clustered separately from American and African groups.
T
ickborne relapsing fever (TBRF) is caused by Borrelia
species and is transmitted to humans by Ornithodoros
soft ticks. Worldwide, a dozen Borrelia species are known
to cause this disease (1). In Israel, TBRF is considered to
be caused by Borrelia persica and transmitted by the cave
tick Ornithodoros tholozani (1). This tick and TBRF are
distributed through Central Asia (2) and the Middle East
(1). Other Borrelia species that cause TBRF have been
described in Iran (3), but their precise range of distribution
is not known.
In Israel, from 1980 through 2002, 184 cases of TBRF
were reported among the civilian population (8
cases/year), and 88% of the case-patients were infected in
caves (4). Among military personnel, TBRF incidence
averages 6.4 cases/100,000 persons (5). In Jordan, an aver-
age of 72 civilian cases per year was reported from 1959
through 1969 (6). In Iran, an average of 100 cases per year
has been recently reported (7).
TBRF in Israel was first reported by Nicholson (8) at
the time World War I. Detailed clinical and epidemiologic
features of the disease are well described in this article,
particularly the transmission by ticks (8). However,
Nicholson incorrectly attributed the disease to the soft tick
Argas persicus. In 1937, Adler et al. clearly identified O.
papillipes (tholozani) as the vector of the disease (9) and
characterized the causative agent as Spirochaeta persica
(10).
Although American (11) and African TBRF Borrelia
(12) are now better characterized, no definitive molecular
characterization of Borrelia species responsible for relaps-
ing fever has been achieved in Israel. The aim of this study
is to provide initial molecular characterization of the etio-
logic agent of TBRF in Israel from both ticks and human
samples and to compare it with previously described
agents of TBRF in other parts of the world.
The Study
We designed a genus-specific set of primers (BOR1: 5′
TAA TAC GTC AGC CAT AAA TGC 3′and BOR2: 5′
GCT CTTTGATCAGTTATC ATT C 3′) that targeted the
Borrelia flaB flagellin gene (13). Each PCR mixture (25
µL) contained 3 µL of target DNA and was subjected to 1
min at 95°C, followed by 40 cycles of 56°C for 30 sec,
72°C for 30 sec, 94°C for 30 sec, and 5 min at 72°C for
final elongation. DNA of B. duttonii and B. burgdorferi
sensu stricto (strain B31) was used as controls. DNA of
blood and ticks was extracted with the DNAeasy tissue kit
(Qiagen, Hilden, Germany). Tick samples were collected
by using CO2 traps in caves and were identified as
Ornithodoros tholozani (Figure 1) by the Entomology
Laboratory (Ministry of Health, Jerusalem). The tick spec-
imens collected were tested either individually or as pools.
Of 184 tick specimens collected from 5 different areas
(Table 1), 94 were tested by BOR1-BOR2 PCR. One pool
of 5, a pool of 4, and 6 individual specimens were positive;
all produced a unique band 750 bp in length. The percent-
age of tick infection was variable, ranging from <2% in
Ma’ale-Adumim to 40% in the Be’er Sheva region.
For patients, the TBRF diagnosis was established as
previously reported (5). Eighteen samples of human blood
were sent to the Parasitology Reference Center (Ministry
of Health, Jerusalem); the samples corresponded to 15
confirmed cases (positive blood smear) and 3 associated
cases of TBRF (negative blood smear). On receipt at the
laboratory, fresh human blood samples were examined by
darkfield microscopy for viable Borrelia and, if detected,
200 µL of blood was injected into 10-mL vials of BSK-H
medium (14) and into 10-week-old ICR mice by the
intraperitoneal route. In 4 patients, blood examined by
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Hadassah Faculty of Medicine, Jerusalem, Israel Figure 1. Ornithodoros tholozani ventral (A) and  dorsal (B) views. 
ABdarkfield microcopy showed 1–5 motile Borrelia per slide.
In vitro cultivation was unsuccessful. However, Borrelia
(1–5/field) were detected on day 4 (twice) and day 6
(twice) in the blood of mice injected intraperitoneally with
patient blood. Cultivation attempts from positive mice
blood were also unsuccessful. In contrast, all the samples
were found positive by BOR1-BOR2 PCR, showing a
unique band of 750 bp (data not shown).
PCR products were cloned in T7 plasmid by pGEM-T
Easy vector SystemII (Promega, Madison, WI, USA).
Plasmids containing inserts were purified and sent for 2-
strand sequencing. Direct sequencing of DNA amplified
by the BOR1 and BOR2 primers was performed later.
Phylogenetic and molecular evolutionary analyses were
conducted by using MEGA version 3.1 (15). Among pub-
lished  flaB genes of TBRF Borrelia strains, only
sequences for which a translated protein existed were
taken in account. Because of the large number of available
sequences for American Borrelia associated with TBRF, as
well as for B. duttonii and B. recurrentis, a single sequence
representative of each cluster was chosen for taxonomic
analyses.
Three PCR amplicons (from 1 tick and 2 human sam-
ples) were sequenced after cloning, whereas 6 amplicons
(from 2 ticks and 4 human samples) were analyzed by
direct sequencing. These 9 sequenced samples showed
98%–100% homology between them and could be divided
into 3 groups. The same DNA sequence was found in tick
TG52 and in blood from 2 patients, HumanBlood2 and
HumanBlood4. These 3 sequences had an additional triplet
at the position 627. The second group of sequences, which
consisted of tick samples TGd1 and CBkc7 and blood sam-
ples C1025B, FL1, and HumanBlood3, were identical,
with only 3 minor substitutions between them. The third
group consisted of the HumanBlood1 sample.
All the translated sequenced amplicons showed a very
specific signature by the presence of a 7–amino acid (aa)
gap at position 216 (see online Appendix Figure, available
from http://www.cdc.gov/ncidod/EID/vol12no11/06-
0715-appG.htm) when compared with previously
described TBRF Borrelia flaB genes. In addition, the local
TBRF Borrelia sequences could be grouped into 3 sub-
types, according to variation at 7-aa positions (Table 2).
Comparison with published flaB protein sequences of
TBRF Borrelia showed 88%–90% homology with B. dut-
tonii and  B. recurrentis, 85%–90% with B. crocidurae,
86%–88% with B. turicatae, 87%–89% with B. hermsii,
and 85%–88% with B. parkeri. The sequences of the Israel
TBRF  Borrelia isolated from different samples clearly
clustered in a separate group from the American and the
African TBRF species (Figure 2).
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Our results suggest that infection rates differ according
to location, despite the small number of ticks tested and the
use of pools. BOR1-BOR2 PCR was more sensitive than
blood smear examination (100% vs 83%). An identical
DNA sequence was found in both tick and patient samples
and thus confirms, at the molecular level, the role of O.
tholozani as the vector of TBRF in Israel.
A signature (7-aa gap) of the flaB flagellin defined the
Israeli TBRF sequences as a homologous group different
from other TBRF species. Despite the small number of
samples studied, a clear polymorphism existed also at the
protein level, resulting in 3 local types. This diversity can
be explained by the use of direct sequencing of samples
rather than through cultivation that reduces the biodiversi-
ty of isolates by selecting the most successful in vitro
clone.
This study opens a new avenue in TBRF Borrelia stud-
ies by demonstrating a Middle East cluster in addition to
the American and African groups. These results open
encouraging perspectives for the better understanding of
entomologic, epidemiologic, and bacteriologic aspects of
this disease and may contribute to better diagnosis and
treatment.
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